LINC01299

Across TCGA pan-cancer cohorts, LINC01299 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC01299 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC01299 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01299 expression acts as an unfavorable survival marker, although some lineages such as LUAD and UCS show a favorable association.

KIRC, UVM, and BRCA are the cancer types where LINC01299 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.526	0.674	<.001	87	view →
UVM	OS	Tertile	III,IV	0.194	0.697	.008	27	view →
BRCA	OS	Tertile	All	0.942	0.968	.023	27	view →
LUAD	DFS	Median	All	0.870	0.766	.011	25	view →
ACC	DFS	Quartile	All	0.443	0.775	.024	19	view →
UCS	OS	Tertile	III,IV	0.805	0.474	.033	18	view →
KIRP	DFS	Tertile	III,IV	0.211	0.724	.011	18	view →
COAD	OS	Tertile	All	0.757	0.886	.023	9	view →
OV	DFS	Quartile	IV	0.278	0.505	.016	6	view →
LIHC	OS	Tertile	All	0.242	0.524	.007	6	view →
UCEC	OS	Tertile	All	0.833	0.888	.045	4	view →
STAD	DFS	Quartile	IV	0.136	0.552	.025	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC01299–KIRC (OS)

Open the KIRC breakdown →